Nabumetone

Approved Uses

Nabumetone is primarily prescribed to manage the symptoms of chronic joint conditions. It is indicated for the treatment of:

• Osteoarthritis: A condition involving the breakdown of joint cartilage and underlying bone.
• Rheumatoid arthritis: An autoimmune disease that causes painful inflammation and swelling in the lining of the joints.

The medication is used for both the short-term treatment of acute flare-ups and the long-term management of chronic symptoms.

Symptoms Managed

By reducing inflammation in the body, nabumetone helps to alleviate several physical symptoms associated with arthritis, including:

• Joint pain and tenderness
• Swelling and redness around the joints
• Stiffness, especially morning stiffness or stiffness after periods of inactivity

The goal of treatment is to improve physical function and make daily activities more comfortable by controlling these inflammatory symptoms.

Mechanism of Action

Nabumetone belongs to a class of medications known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by interfering with the body's production of prostaglandins, which are natural substances that contribute to pain, fever, and inflammation.

Unlike some other NSAIDs, nabumetone is considered a prodrug. This means that when the medication is swallowed, it is not yet in its active form. Once it passes through the digestive system and is processed by the liver, the body converts it into an active chemical called 6-methoxy-2-naphthylacetic acid (6-MNA).

This active form then works by:

• Inhibiting enzymes: It blocks enzymes called cyclooxygenase (COX). These enzymes are responsible for creating prostaglandins.
• Reducing prostaglandins: By blocking these enzymes, the body produces fewer prostaglandins at the site of injury or joint damage.
• Relieving symptoms: Lower levels of prostaglandins lead to a decrease in swelling, redness, and the sensation of pain associated with conditions like arthritis.

Common Side Effects

Some people may experience mild side effects while taking nabumetone. These often include:

• Stomach pain, gas, or bloating
• Diarrhea or constipation
• Nausea and vomiting
• Dizziness or headache
• Ringing in the ears

Serious Side Effects

Seek medical attention immediately if you experience any of the following serious symptoms:

• Gastrointestinal problems: Black, bloody, or tarry stools; coughing up blood; or vomit that resembles coffee grounds.
• Cardiovascular signs: Chest pain, shortness of breath, sudden weakness on one side of the body, or slurred speech.
• Allergic reactions: Skin rash, itching, hives, or swelling of the face, tongue, or throat.
• Organ dysfunction: Yellowing of the eyes or skin (jaundice), dark urine, or unusual swelling in the arms, legs, or feet.
• Vision changes: Blurred vision or other disturbances in sight.

Boxed Warnings

Cardiovascular Risk: Nonsteroidal anti-inflammatory drugs (NSAIDs), including nabumetone, may increase the risk of serious cardiovascular thrombotic events, myocardial infarction (heart attack), and stroke, which can be fatal. This risk may occur early in treatment and may increase with the duration of use.

Gastrointestinal Risk: Nabumetone increases the risk of serious gastrointestinal (GI) adverse events, including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients and those with a prior history of peptic ulcer disease or GI bleeding are at greater risk.

Contraindications

• Nabumetone is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery.
• It should not be used by individuals who have experienced asthma, hives, or allergic-type reactions after taking aspirin or other NSAIDs.
• It is contraindicated in patients with known hypersensitivity to nabumetone.

Other Precautions

Kidney and Liver Function: Long-term use of NSAIDs can result in kidney injury, including renal papillary necrosis. Patients with pre-existing kidney disease, heart failure, or liver dysfunction, and those taking certain medications like diuretics or ACE inhibitors, are at higher risk. Elevations of liver enzymes may also occur during treatment.

Severe Skin Reactions: NSAIDs can cause serious skin adverse events such as exfoliative dermatitis, Stevens-Johnson Syndrome (SJS), and toxic epidermal necrolysis (TEN), which can be fatal. Treatment should be discontinued at the first appearance of a skin rash or any other sign of hypersensitivity.

Pregnancy: Use of nabumetone should be avoided in late pregnancy (starting at 30 weeks) because it may cause premature closure of the ductus arteriosus in the fetus. It may also cause kidney problems in the unborn baby if taken after 20 weeks of pregnancy.

Anaphylactic Reactions: Serious allergic reactions can occur even in patients without known prior exposure to nabumetone. Emergency help should be sought if signs of a severe reaction occur.

Pregnancy

Nabumetone is typically not recommended for use during pregnancy, particularly during the second and third trimesters. Healthcare providers generally advise against taking nonsteroidal anti-inflammatory drugs (NSAIDs) like nabumetone starting at 20 weeks of pregnancy because they may cause rare but serious kidney problems in the unborn baby, which can lead to low levels of amniotic fluid.

Nabumetone should be strictly avoided starting at 30 weeks of pregnancy. At this stage, the medication can cause the premature closure of the ductus arteriosus, a critical blood vessel in the baby's heart. If you are pregnant or planning to become pregnant, it is important to discuss the potential risks and benefits of this medication with your doctor.

Breastfeeding

It is currently unknown if nabumetone passes into human breast milk. Because many medications are excreted in milk and could potentially cause serious side effects in a nursing infant, you should consult your healthcare provider to decide whether to continue breastfeeding or stop taking the medication.

Available Forms

Nabumetone is provided in the following form for oral use:

• Oral tablet

FDA Approval and Indications

Nabumetone was approved by the U.S. Food and Drug Administration (FDA) for the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthritis. It is classified as a nonsteroidal anti-inflammatory drug (NSAID).

Boxed Warning

The FDA requires a boxed warning for nabumetone, which is the highest level of safety alert. This warning highlights two major areas of concern:

• Cardiovascular Risk: Nonsteroidal anti-inflammatory drugs (NSAIDs) may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction (heart attack), and stroke, which can be fatal. This risk may increase with the duration of use and may be higher in patients with cardiovascular disease or risk factors for cardiovascular disease.
• Gastrointestinal Risk: NSAIDs cause an increased risk of serious gastrointestinal (GI) adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients are at a greater risk for serious gastrointestinal events.

Regulatory Status

Nabumetone is available only by prescription. It is not a controlled substance. To ensure patient safety, the FDA requires that a Medication Guide be provided to patients each time the prescription is filled, detailing the risks of cardiovascular and gastrointestinal complications.

Generic Availability

Nabumetone is widely available as a generic drug. Generic medications are required to have the same active ingredients and effectiveness as brand-name versions but are usually sold at a significantly lower cost.

Insurance and Coverage

Most health insurance plans, including Medicare Part D and Medicaid, provide coverage for generic nabumetone. The specific out-of-pocket cost will depend on the individual's insurance plan, including any deductibles, copayments, or coinsurance requirements.

Factors Affecting Cost

The price of nabumetone can vary based on several factors:

• Pharmacy Choice: Retail prices can differ between large chain pharmacies, independent drugstores, and mail-order services.
• Prescription Quantity: Purchasing a 90-day supply may offer a lower cost per tablet than a standard 30-day supply.
• Dosage Strength: The medication is commonly available in 500 mg and 750 mg tablets, and pricing may vary slightly between these strengths.

For individuals without insurance, pharmacy discount cards or coupons may be available to help reduce the retail price. It is recommended to compare prices at different pharmacies to find the most cost-effective option.